GENEMAP OF THE HUMAN GENES ASSOCIATED WITH SCHIZOPHRENIA
The present invention relates to the selection of a set of polymorphism markers for use in genome wide association studies based on linkage disequilibrium mapping. In particular, the invention relates to the fields of pharmacogenomics, diagnostics, patient therapy and the use of genetic haplotype in...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | SEGAL, JONATHAN KEITH, TIM DUBOIS, DANIEL CROTEAU, PASCAL PAQUIN, NOUZHA BELOUCHI, ABDELMAJID PAQUIN, BRUNO FOURNIER, HELENE RAELSON, JOHN VERNER BRADLEY, WALTER EDWARD VAN EERDEWEGH, PAUL LITTLE, RANDALL, DAVID BRUAT, VANESSA |
description | The present invention relates to the selection of a set of polymorphism markers for use in genome wide association studies based on linkage disequilibrium mapping. In particular, the invention relates to the fields of pharmacogenomics, diagnostics, patient therapy and the use of genetic haplotype information to predict an individual's susceptibility to SCHIZOPHRENIA disease and/or their response to a particular drug or drugs.
Cette invention concerne la sélection d'un ensemble de marqueurs de polymorphisme utilisables dans les études d'association sur le génome entier reposant sur la cartographie des déséquilibres de liaison. En particulier, l'invention concerne les domaines de la pharmacogénomique, du diagnostic, du traitement thérapeutique, et l'utilisation des données concernant les haplotypes génétiques pour prédire la sensibilité d'un sujet à la schizophrénie et/ou sa réponse à un/des médicament(s) donné(s). |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2008112177A2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2008112177A2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2008112177A23</originalsourceid><addsrcrecordid>eNrjZLBwd_Vz9XUMUPB3UwjxcFXwCPV19FMACQYrOAYH-zt7Ooa4uiiEe4Z4KAQ7e3hG-Qd4BLn6eTryMLCmJeYUp_JCaW4GZTfXEGcP3dSC_PjU4oLE5NS81JL4cH8jAwMLQ0MjQ3NzRyNj4lQBAOv0KTw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>GENEMAP OF THE HUMAN GENES ASSOCIATED WITH SCHIZOPHRENIA</title><source>esp@cenet</source><creator>SEGAL, JONATHAN ; KEITH, TIM ; DUBOIS, DANIEL ; CROTEAU, PASCAL ; PAQUIN, NOUZHA ; BELOUCHI, ABDELMAJID ; PAQUIN, BRUNO ; FOURNIER, HELENE ; RAELSON, JOHN VERNER ; BRADLEY, WALTER EDWARD ; VAN EERDEWEGH, PAUL ; LITTLE, RANDALL, DAVID ; BRUAT, VANESSA</creator><creatorcontrib>SEGAL, JONATHAN ; KEITH, TIM ; DUBOIS, DANIEL ; CROTEAU, PASCAL ; PAQUIN, NOUZHA ; BELOUCHI, ABDELMAJID ; PAQUIN, BRUNO ; FOURNIER, HELENE ; RAELSON, JOHN VERNER ; BRADLEY, WALTER EDWARD ; VAN EERDEWEGH, PAUL ; LITTLE, RANDALL, DAVID ; BRUAT, VANESSA</creatorcontrib><description>The present invention relates to the selection of a set of polymorphism markers for use in genome wide association studies based on linkage disequilibrium mapping. In particular, the invention relates to the fields of pharmacogenomics, diagnostics, patient therapy and the use of genetic haplotype information to predict an individual's susceptibility to SCHIZOPHRENIA disease and/or their response to a particular drug or drugs.
Cette invention concerne la sélection d'un ensemble de marqueurs de polymorphisme utilisables dans les études d'association sur le génome entier reposant sur la cartographie des déséquilibres de liaison. En particulier, l'invention concerne les domaines de la pharmacogénomique, du diagnostic, du traitement thérapeutique, et l'utilisation des données concernant les haplotypes génétiques pour prédire la sensibilité d'un sujet à la schizophrénie et/ou sa réponse à un/des médicament(s) donné(s).</description><language>eng ; fre</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS OR TEST PAPERS THEREFOR ; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ; ENZYMOLOGY ; MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS ; METALLURGY ; MICROBIOLOGY ; MUTATION OR GENETIC ENGINEERING ; PROCESSES OF PREPARING SUCH COMPOSITIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2008</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20080918&DB=EPODOC&CC=WO&NR=2008112177A2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20080918&DB=EPODOC&CC=WO&NR=2008112177A2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SEGAL, JONATHAN</creatorcontrib><creatorcontrib>KEITH, TIM</creatorcontrib><creatorcontrib>DUBOIS, DANIEL</creatorcontrib><creatorcontrib>CROTEAU, PASCAL</creatorcontrib><creatorcontrib>PAQUIN, NOUZHA</creatorcontrib><creatorcontrib>BELOUCHI, ABDELMAJID</creatorcontrib><creatorcontrib>PAQUIN, BRUNO</creatorcontrib><creatorcontrib>FOURNIER, HELENE</creatorcontrib><creatorcontrib>RAELSON, JOHN VERNER</creatorcontrib><creatorcontrib>BRADLEY, WALTER EDWARD</creatorcontrib><creatorcontrib>VAN EERDEWEGH, PAUL</creatorcontrib><creatorcontrib>LITTLE, RANDALL, DAVID</creatorcontrib><creatorcontrib>BRUAT, VANESSA</creatorcontrib><title>GENEMAP OF THE HUMAN GENES ASSOCIATED WITH SCHIZOPHRENIA</title><description>The present invention relates to the selection of a set of polymorphism markers for use in genome wide association studies based on linkage disequilibrium mapping. In particular, the invention relates to the fields of pharmacogenomics, diagnostics, patient therapy and the use of genetic haplotype information to predict an individual's susceptibility to SCHIZOPHRENIA disease and/or their response to a particular drug or drugs.
Cette invention concerne la sélection d'un ensemble de marqueurs de polymorphisme utilisables dans les études d'association sur le génome entier reposant sur la cartographie des déséquilibres de liaison. En particulier, l'invention concerne les domaines de la pharmacogénomique, du diagnostic, du traitement thérapeutique, et l'utilisation des données concernant les haplotypes génétiques pour prédire la sensibilité d'un sujet à la schizophrénie et/ou sa réponse à un/des médicament(s) donné(s).</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS OR TEST PAPERS THEREFOR</subject><subject>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</subject><subject>ENZYMOLOGY</subject><subject>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>PROCESSES OF PREPARING SUCH COMPOSITIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2008</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLBwd_Vz9XUMUPB3UwjxcFXwCPV19FMACQYrOAYH-zt7Ooa4uiiEe4Z4KAQ7e3hG-Qd4BLn6eTryMLCmJeYUp_JCaW4GZTfXEGcP3dSC_PjU4oLE5NS81JL4cH8jAwMLQ0MjQ3NzRyNj4lQBAOv0KTw</recordid><startdate>20080918</startdate><enddate>20080918</enddate><creator>SEGAL, JONATHAN</creator><creator>KEITH, TIM</creator><creator>DUBOIS, DANIEL</creator><creator>CROTEAU, PASCAL</creator><creator>PAQUIN, NOUZHA</creator><creator>BELOUCHI, ABDELMAJID</creator><creator>PAQUIN, BRUNO</creator><creator>FOURNIER, HELENE</creator><creator>RAELSON, JOHN VERNER</creator><creator>BRADLEY, WALTER EDWARD</creator><creator>VAN EERDEWEGH, PAUL</creator><creator>LITTLE, RANDALL, DAVID</creator><creator>BRUAT, VANESSA</creator><scope>EVB</scope></search><sort><creationdate>20080918</creationdate><title>GENEMAP OF THE HUMAN GENES ASSOCIATED WITH SCHIZOPHRENIA</title><author>SEGAL, JONATHAN ; KEITH, TIM ; DUBOIS, DANIEL ; CROTEAU, PASCAL ; PAQUIN, NOUZHA ; BELOUCHI, ABDELMAJID ; PAQUIN, BRUNO ; FOURNIER, HELENE ; RAELSON, JOHN VERNER ; BRADLEY, WALTER EDWARD ; VAN EERDEWEGH, PAUL ; LITTLE, RANDALL, DAVID ; BRUAT, VANESSA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2008112177A23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2008</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS OR TEST PAPERS THEREFOR</topic><topic>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</topic><topic>ENZYMOLOGY</topic><topic>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>PROCESSES OF PREPARING SUCH COMPOSITIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>SEGAL, JONATHAN</creatorcontrib><creatorcontrib>KEITH, TIM</creatorcontrib><creatorcontrib>DUBOIS, DANIEL</creatorcontrib><creatorcontrib>CROTEAU, PASCAL</creatorcontrib><creatorcontrib>PAQUIN, NOUZHA</creatorcontrib><creatorcontrib>BELOUCHI, ABDELMAJID</creatorcontrib><creatorcontrib>PAQUIN, BRUNO</creatorcontrib><creatorcontrib>FOURNIER, HELENE</creatorcontrib><creatorcontrib>RAELSON, JOHN VERNER</creatorcontrib><creatorcontrib>BRADLEY, WALTER EDWARD</creatorcontrib><creatorcontrib>VAN EERDEWEGH, PAUL</creatorcontrib><creatorcontrib>LITTLE, RANDALL, DAVID</creatorcontrib><creatorcontrib>BRUAT, VANESSA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SEGAL, JONATHAN</au><au>KEITH, TIM</au><au>DUBOIS, DANIEL</au><au>CROTEAU, PASCAL</au><au>PAQUIN, NOUZHA</au><au>BELOUCHI, ABDELMAJID</au><au>PAQUIN, BRUNO</au><au>FOURNIER, HELENE</au><au>RAELSON, JOHN VERNER</au><au>BRADLEY, WALTER EDWARD</au><au>VAN EERDEWEGH, PAUL</au><au>LITTLE, RANDALL, DAVID</au><au>BRUAT, VANESSA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>GENEMAP OF THE HUMAN GENES ASSOCIATED WITH SCHIZOPHRENIA</title><date>2008-09-18</date><risdate>2008</risdate><abstract>The present invention relates to the selection of a set of polymorphism markers for use in genome wide association studies based on linkage disequilibrium mapping. In particular, the invention relates to the fields of pharmacogenomics, diagnostics, patient therapy and the use of genetic haplotype information to predict an individual's susceptibility to SCHIZOPHRENIA disease and/or their response to a particular drug or drugs.
Cette invention concerne la sélection d'un ensemble de marqueurs de polymorphisme utilisables dans les études d'association sur le génome entier reposant sur la cartographie des déséquilibres de liaison. En particulier, l'invention concerne les domaines de la pharmacogénomique, du diagnostic, du traitement thérapeutique, et l'utilisation des données concernant les haplotypes génétiques pour prédire la sensibilité d'un sujet à la schizophrénie et/ou sa réponse à un/des médicament(s) donné(s).</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; fre |
recordid | cdi_epo_espacenet_WO2008112177A2 |
source | esp@cenet |
subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ENZYMOLOGY MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS METALLURGY MICROBIOLOGY MUTATION OR GENETIC ENGINEERING PROCESSES OF PREPARING SUCH COMPOSITIONS SPIRITS VINEGAR WINE |
title | GENEMAP OF THE HUMAN GENES ASSOCIATED WITH SCHIZOPHRENIA |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T04%3A55%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SEGAL,%20JONATHAN&rft.date=2008-09-18&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2008112177A2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |